Overview

• Initial prescriptions would require an in‑person doctor visit, with video consultations no longer sufficient for a first script.
• Follow‑up prescriptions could be issued via telemedicine after the first visit, with at least one on‑site consultation required in each four‑quarter period.
• Mail‑order sales of cannabis flowers for medical use would be banned, while pharmacy delivery services would remain allowed.
• Pharmacies would be required to provide personal counselling before dispensing medicinal cannabis.
• Government data cite imports up 170% from H1 to H2 2024 and more than 400% year over year to about 80 tonnes in H1 2025, while statutory‑insurance prescriptions rose by roughly 9%.